Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niclas E Bengtsson

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2025
The road toward AAV-mediated gene therapy of Duchenne muscular dystrophyNiclas E Bengtsson, Hichem Tasfaout, Jeffrey S Chamberlain
Current Pediatrics Reports|June 3, 2014
Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular DystrophyJane T Seto, Niclas E Bengtsson, Jeffrey S Chamberlain
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2020
Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac MusclesNiclas E Bengtsson, Hichem Tasfaout, Stephen D Hauschka, et al.
Magnetic Resonance in Medicine|February 11, 2010
lacZ as a genetic reporter for real-time MRINiclas E Bengtsson, Gary Brown, Edward W Scott, et al.
Human Molecular Genetics|October 10, 2015
Progress and prospects of gene therapy clinical trials for the muscular dystrophiesNiclas E Bengtsson, Jane T Seto, John K Hall, et al.
Plos One|October 27, 2018
Non-invasive tracking of disease progression in young dystrophic muscles using multi-parametric MRI at 14TJoshua S Park, Ravneet Vohra, Thomas Klussmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2019
Development of Novel Micro-dystrophins with Enhanced FunctionalityJulian N Ramos, Katrin Hollinger, Niclas E Bengtsson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2022
Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal modelNiclas E Bengtsson, Julie M Crudele, Jordan M Klaiman, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 30, 2012
Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imagingParvesh Sharma, Niclas E Bengtsson, Glenn A Walter, et al.
Nature Communications|June 24, 2017
Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophyNiclas E Bengtsson, John K Hall, Guy L Odom, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2025
The road toward AAV-mediated gene therapy of Duchenne muscular dystrophyNiclas E Bengtsson, Hichem Tasfaout, Jeffrey S Chamberlain
Current Pediatrics Reports|June 3, 2014
Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular DystrophyJane T Seto, Niclas E Bengtsson, Jeffrey S Chamberlain
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2020
Dystrophin Gene-Editing Stability Is Dependent on Dystrophin Levels in Skeletal but Not Cardiac MusclesNiclas E Bengtsson, Hichem Tasfaout, Stephen D Hauschka, et al.
Magnetic Resonance in Medicine|February 11, 2010
lacZ as a genetic reporter for real-time MRINiclas E Bengtsson, Gary Brown, Edward W Scott, et al.
Human Molecular Genetics|October 10, 2015
Progress and prospects of gene therapy clinical trials for the muscular dystrophiesNiclas E Bengtsson, Jane T Seto, John K Hall, et al.
Plos One|October 27, 2018
Non-invasive tracking of disease progression in young dystrophic muscles using multi-parametric MRI at 14TJoshua S Park, Ravneet Vohra, Thomas Klussmann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2019
Development of Novel Micro-dystrophins with Enhanced FunctionalityJulian N Ramos, Katrin Hollinger, Niclas E Bengtsson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2022
Comparison of dystrophin expression following gene editing and gene replacement in an aged preclinical DMD animal modelNiclas E Bengtsson, Julie M Crudele, Jordan M Klaiman, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 30, 2012
Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imagingParvesh Sharma, Niclas E Bengtsson, Glenn A Walter, et al.
Nature Communications|June 24, 2017
Corrigendum: Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophyNiclas E Bengtsson, John K Hall, Guy L Odom, et al.
Pageof 2